Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001510580-16-000004
Filing Date
2016-11-09
Accepted
2016-11-09 08:56:12
Documents
92
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kite10q9-30x16.htm 10-Q 1166345
2 EXHIBIT 10.1 kiteex-1019x30x16.htm EX-10.1 1046797
3 EXHIBIT 31.1 kiteex-3119x30x16.htm EX-31.1 10951
4 EXHIBIT 31.2 kiteex-3129x30x16.htm EX-31.2 9655
5 EXHIBIT 32.1 kiteex-3219x30x16.htm EX-32.1 4646
6 EXHIBIT 32.2 kiteex-3229x30x16.htm EX-32.2 4726
13 a1exibit.jpg GRAPHIC 88430
14 bexibit.jpg GRAPHIC 104772
15 fexibita01.jpg GRAPHIC 80643
16 k1exibit.jpg GRAPHIC 65759
17 k2exibit.jpg GRAPHIC 51658
18 oexibit.jpg GRAPHIC 11223
19 wla760812v6bostonpro_image10.jpg GRAPHIC 63059
20 wla760812v6bostonprop_image1.jpg GRAPHIC 644971
21 wla760812v6bostonprop_image2.jpg GRAPHIC 613255
22 wla760812v6bostonprop_image3.jpg GRAPHIC 793377
23 wla760812v6bostonprop_image4.jpg GRAPHIC 735721
24 wla760812v6bostonprop_image5.jpg GRAPHIC 719453
25 wla760812v6bostonprop_image8.gif GRAPHIC 94341
  Complete submission text file 0001510580-16-000004.txt   13250254

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT kite-20160930.xml EX-101.INS 1219195
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kite-20160930.xsd EX-101.SCH 59329
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kite-20160930_cal.xml EX-101.CAL 84200
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kite-20160930_def.xml EX-101.DEF 308911
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kite-20160930_lab.xml EX-101.LAB 729474
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kite-20160930_pre.xml EX-101.PRE 475550
Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Filer) CIK: 0001510580 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-36508 | Film No.: 161982900
SIC: 2836 Biological Products, (No Diagnostic Substances)